VARKI PAUL
Chief Legal Officer
VARKI PAUL has filed 4 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jun 12, 2026.
On the most recent filing, VARKI PAUL is listed as Chief Legal Officer at Avalo Therapeutics, Inc. Inside the rolling window, VARKI PAUL reported no open-market purchases and 1 open-market sale totaling $1.5M in AVTX.
Companies traded
Other insiders at AVTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has VARKI PAUL made?
VARKI PAUL has filed 4 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.
Which companies does VARKI PAUL trade?
VARKI PAUL has filed SEC Form 4 disclosures for 1 company, including AVTX.
When was VARKI PAUL's most recent SEC Form 4 filing?
VARKI PAUL's most recent SEC Form 4 filing on Tracefour is dated Jun 12, 2026.
What is VARKI PAUL's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, VARKI PAUL is listed as Chief Legal Officer.
What is VARKI PAUL's total buy and sell value in the current window?
Inside the rolling retention window, VARKI PAUL bought $0 and sold $1.5M based on SEC Form 4 filings.
What was VARKI PAUL's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 75,063 AVTX shares on 2026-05-06, worth $1.5M, per SEC Form 4 filings.